EGFR and breast carcinoma: Guo et al. developed an EGFR-targeted multifunctional micellar nanoplatform by encapsulating celecoxib and doxorubicin (DOX) into polymeric micelles based on the conjugate of GE11-PEG-b-poly(trimethylene carbonate) to suppress metastatic breast cancer proliferation and metastasis [116].